NCT06666166 2024-10-30
SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer
China Medical University, China
Phase 2 Not yet recruiting
Clinical Trials
8 trialsNCT06642857 2024-10-15
Multi-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gastric/Gastroesophageal Junction Cancer.
Zhejiang Cancer Hospital
Recruiting
NCT05997524 2023-08-18
Clinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-positive Advanced Gastric Cancer.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 2 Completed
NCT05334849 2022-10-12
Prospectively Predict the Immunotherapy Response of Gastric Cancer Based on Circulating Exosomal LncRNA-GC1 Biopsy
Chinese PLA General Hospital
Completed
NCT05351398 2022-04-28
The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Gastric Cancer
Shanghai Minimally Invasive Surgery Center
Unknown
NCT05313906 2022-04-06
RC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT05270824 2022-03-08
Study Evaluating Neoadjuvant Immunotherapy Increasing CD8+ Cell Infiltration in Advance Gastric Adenocarcinoma
Fujian Medical University
Phase 3 Not yet recruiting
NCT02163291 2014-06-13
Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer
Peking University
Phase 2 Unknown